Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.29 -0.02 (-0.87%)
At close: Oct 23, 2026 · 4:00 PM EDT

Rocket Pharmaceuticals (RCKT) Net Debt Issuances and Repayments (2014 - 2015)

Updated

Analysis

Rocket Pharmaceuticals (RCKT) Net Debt Issuances and Repayments (2014 - 2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -4.36 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -2.00 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -2.46 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -17.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 64.00 Mn
10 Rocket Pharmaceuticals 250.85 Mn -32.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 15.20 Mn
Dec 31, 2014 -715,000.00
API Access

Rocket Pharmaceuticals Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=RCKT&period=max&api_key=YOUR_API_KEY